Free radicals and antioxidants in normal physiological functions and human disease

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 1, 2007, Pages 44-84

  Valko, Marian ^a   Leibfritz, Dieter ^b   Moncol, Jan ^a   Cronin, Mark T D ^c   Mazur, Milan ^a   Telser, Joshua ^d  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^b UNIVERSITY OF BREMEN   (Germany)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^d ROOSEVELT UNIVERSITY   (United States)

Author keywords

Antioxidants; Human disease; Nitric oxide; Oxidative stress; Reactive oxygen species; Redox regulation

Indexed keywords

4 HYDROXYNONENAL; ACROLEIN; ALPHA SYNUCLEIN; ANTIOXIDANT; CADMIUM; CYTOKINE; DNA; FREE RADICAL; GLUTATHIONE; GLUTATHIONE DISULFIDE; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROSTANE DERIVATIVE; LIPID; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MATRIX METALLOPROTEINASE; PROTEIN; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE PHOSPHATASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TOBACCO SMOKE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT;

AGING; ALZHEIMER DISEASE; ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROSIS; BIOCHEMISTRY; CALORIC RESTRICTION; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DNA DAMAGE; GENE MUTATION; HEART MUSCLE ISCHEMIA; HOMEOSTASIS; HUMAN; HYPERTENSION; ISCHEMIC PRECONDITIONING; NITROSYLATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PARKINSON DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN DEGRADATION; REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; ARTHRITIS, RHEUMATOID; BRAIN DISEASES; CARDIOVASCULAR DISEASES; CELL AGING; DIABETES MELLITUS; HUMANS; NEOPLASMS; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 33749986298     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.07.001     Document Type: Review

References (263)

1. Abe J., and Berk B.C. Fyn and JAK2 mediate Ras activation by reactive oxygen species. J. Biol. Chem. 274 (1999) 21003-21010
2. Acker H., and Xue D.H. Mechanisms of O-2 sensing in the carotid-body in comparison with other O-2 sensing cells. News Physiol. Sci. 10 (1995) 211-216
3. Adams J.M. Ways of dying: Multiple pathways to apoptosis. Genes Dev. 17 (2003) 2481-2495
4. Aikens J., and Dix T.A. Perhydroxyl radical (HOO{radical dot}) Initiated lipid-peroxidation-The role of fatty-acid hydroperoxides. J. Biol. Chem. 266 (1991) 15091-15098
5. Albelda S.M., Smith C.W., and Ward P.A. Adhesion molecules and inflammatory injury. FASEB J. 8 (1994) 504-512
6. Albina J.E., and Reichner J.S. Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metast. Rev. 17 (1998) 39-53
7. Amiri K.I., and Richmond A. Role of nuclear factor-kappa B in melanoma. Cancer Metast. Rev. 24 (2005) 301-313
8. Andersen J.K. Oxidative stress in neurodegeneration: Cause or consequence?. Nat. Rev. Neurosci. 5 (2004) S18-S25
9. Archer S. Measurement of nitric-oxide in biological models. FASEB J. 7 (1993) 349-360
10. Arrigo A.P. Gene expression and the thiol redox state. Free Radic. Biol. Med. 27 (1999) 936-944
11. Aslund F., Zheng M., Beckwith J., and Storz G. Regulation of the OxyR transcription factor by hydrogen peroxide and the cellular thioldisulfide status. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 6161-6165
12. Babior B.M. NADPH oxidase: An update. Blood 93 (1999) 1464-1476
13. Baker A., Payne C.M., Briehl M.M., and Powis G. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res. 57 (1997) 5162-5167
14. Barnett Y.A., and King C.M. Investigation of antioxidant status. DNA-repair capacity and mutation as a function of age in humans. Mut. Res. 338 (1995) 115-128
15. Baud V., and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell. Biol. 11 (2001) 372-377
16. Bauerova K., and Bezek S. Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen. Physiol. Biophys. 18 (1999) 15-20
17. Becker L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61 (2004) 461-470
18. Behrend L., Henderson G., and Zwacka R.M. Reactive oxygen species in oncogenic transformation. Biochem. Soc. Trans. 31 (2003) 1441-1444
19. Bergendi L., Benes L., Durackova Z., and Ferencik M. Chemistry, physiology and pathology of free radicals. Life Sci. 65 (1999) 1865-1874
20. Berry C.E., and Hare J.M. Xanthine oxidoreductase in the cardiovascular system: Molecular mechanisms and pathophysiologic implications. J. Physiol. 555 (2004) 589-606
21. Borges F., Fernandes E., and Roleira F. Progress towards the discovery of xanthine oxidase inhibitors. Curr. Med. Chem. 9 (2002) 195-217
22. Brash A.R. Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 274 (1999) 23679-23682
23. Bredt D.S., Hwang P.M., Glatt C.E., Lowenstein C., Reed R.R., and Synder S.H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome 450 Reductase. Nature 351 (1991) 714-718
24. Brown G.C., and Borutaite V. Nitric oxide, mitochondria, and cell death. IUBMB Life 52 (2001) 189-195
25. Brownlee M., and Cerami A. The biochemistry of the complications of diabetes-mellitus. Ann. Rev. Biochem. 50 (1981) 385-432
26. Brune B., Gotz C., Messmer U.K., Sandau K., Hirvonen M.R., and Lapetina E.G. Superoxide formation and macrophage resistance to nitric oxide-mediated apoptosis. J. Biol. Chem. 272 (1997) 7253-7258
27. Buchanan T.A., Xiang A.H., Peters R.K., Kjos S.L., Marroquin A., Goico J., et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51 (2002) 2796-2803
28. Burton G.W., and Ingold K.U. Beta-carotene-An unusual type of lipid antioxidant. Science 224 (1984) 569-573
29. Bush A.I. The metallobiology of Alzheimer's disease. Trends Neurosci. 26 (2003) 207-214
30. Butler J. Thermodynamic considerations of free radical reactions. In: Rhodes C.J. (Ed). Toxicology of the human environment (2000), Taylor and Francis, London 437-453
31. Butler R., Morris A.D., Belch J.J.F., Hill A., and Struthers A.D. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35 (2000) 746-751
32. Butterfield D.A., Castegna A., Lauderback C.M., and Drake J. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging 23 (2002) 655-664
33. Cadenas E. Basic mechanisms of antioxidant activity. Biofactors 6 (1997) 391-397
34. Cadenas E., and Davies K.J.A. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29 (2000) 222-230
35. Cadenas E., and Sies H. The lag phase. Free. Radic. Res. 28 (1998) 601-609
36. Cai J.Y., and Jones D.P. Communication - superoxide in apoptosis - mitochondrial generation triggered by Cytochrome c loss. J. Biol. Chem. 273 (1998) 11401-11404
37. Cameron E., and Pauling L. Supplemental ascorbate in supportive treatment of cancer - prolongation of survival times in terminal human cancer. Part 1. Proc. Natl. Acad. Sci. U.S.A. 73 (1976) 3685-3689
38. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
39. Carr A., and Frei B. Does Vitamin C act as a pro-oxidant under physiological conditions?. FASEB J. 13 (1999) 1007-1024
40. Carr A., McCall M.R., and Frei B. Oxidation of LDL by myeloperoxidase and reactive nitrogen species-reaction pathways and antioxidant protection. Arterioscl. Thromb. Vasc. Biol. 20 (2000) 1716-1723
41. Catani M.V., Rossi A., Costanzo A., Sabatini S., Levrero M., Melino G., et al. Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage. Biochem. J. 356 (2001) 77-85
42. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arteriosc. Thromb. Vasc. Biol. 24 (2004) 816-823
43. Chapple I.L.C. Reactive oxygen species and antioxidants in inflammatory diseases. J. Clin. Periodontol. 24 (1997) 287-296
44. Chen Z.Y., Siu B., Ho Y.S., Vincent R., Chua C.C., Hamdy R.C., et al. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J. Mol. Cell. Cardiol. 30 (1998) 2281-2289
45. Chiueh C.C. Neuroprotective properties of nitric oxide. Ann. N.Y. Acad. Sci. 890 (1999) 301-311
46. Clancy R.M., Leszczynskapiziak J., and Abramson S.B. Nitric-oxide, an endothelial-cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90 (1992) 1116-1121
47. Commoner B., Townsend J., and Pake G.E. Free radicals in biological materials. Nature 174 (1954) 689-691
48. Cote C.G., Yu F.S., Zulueta J.J., Vosatka R.J., and Hassoun P.M. Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide. Am. J. Physiol. Lung Cell. Mol. Physiol. 15 (1996) L869-L874
49. Cuajungco M.P., and Faget K.Y. Zinc takes the center stage: Its paradoxical role in Alzheimer's disease. Brain Res. Rev. 41 (2003) 44-56
50. Cuajungco M.P., Goldstein L.E., Nunomura A., Smith M.A., Lim J.T., Atwood C.S., et al. Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of A beta by zinc. J. Biol. Chem. 275 (2000) 19439-19442
51. Cuajungco M.P., and Lees G.J. Diverse effects of metal chelating agents on the neuronal cytotoxicity of zinc in the hippocampus. Brain Res. 799 (1998) 97-107
52. Cunnane G., FitzGerald O., Beeton C., Cawston T.E., and Bresnihan B. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis. Arth. Rheumat. 44 (2001) 2263-2274
53. Dalle-Donne I., Giustarini D., Colombo R., Rossi R., and Milzani A. Protein carbonylation in human diseases. Trends Mol. Med. 9 (2003) 169-176
54. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., and Milzani A. Biomarkers of oxidative damage in human disease. Clin. Chem. 52 (2006) 601-623
55. Dalle-Donne I., Scaloni A., Giustarini D., Cavarra E., Tell G., Lungarella G., et al. Proteins as biomarkers of oxidative/nitrosative stress in diseases: The contribution of redox proteomics. Mass Spectrom. Rev. 24 (2005) 55-99
56. Damy T., Ratajczak P., Shah A.M., Camors E., Marty I., Hasenfuss G., et al. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 363 (2004) 1365-1367
57. Danial N.N., and Korsmeyer S.J. Cell death: Critical control points. Cell 116 (2004) 205-219
58. Das D.K., Maulik N., Sato M., and Ray P.S. Reactive oxygen species function as second messenger during ischemic preconditioning of heart. Mol. Cell. Biochem. 196 (1999) 59-67
59. 2{radical dot}: The forgotten radical. DNA Cell Biol. 21 (2002) 251-257
60. DeCoursey T.E., and Ligeti E. Regulation and termination of NADPH oxidase activity. Cell. Mol. Life Sci. 62 (2005) 2173-2193
61. Dempsey E.C., Newton A.C., Mochly-Rosen D., Fields A.P., Reyland M.E., Insel P.A., et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am. J. Physiol.-Lung Cell. Mol. Physiol. 279 (2000) L429-L438
62. Dhalla N.S., Temsah R.M., and Netticadan T. Role of oxidative stress in cardiovascular diseases. J. Hypertens. 18 (2000) 655-673
63. Dikalov S.I., Vitek M.P., and Mason R.P. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical. Free Radic. Biol. Med. 36 (2004) 340-347
64. Dodge-Kafka K.L., Soughayer J., Pare G.C., Michel J.J.C., Langeberg L.K., Kapiloff M.S., et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 437 (2005) 574-578
65. Dreher D., and Junod A.F. Role of oxygen free radicals in cancer development. Eur. J. Cancer. 32A (1996) 30-38
66. Drevs J., Medinger M., Schmidt-Gersbach C., Weber R., and Unger C. Receptor tyrosine kinases: The main targets for new anticancer therapy. Curr. Drug Targ. 4 (2003) 113-121
67. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
68. El-Agamey A., Lowe G.M., McGarvey D.J., Mortensen A., Phillip D.M., and Truscott T.G. Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch. Biochem. Biophys. 430 (2004) 37-48
69. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?. Diabetes 52 (2003) 1-8
70. Evens A.M. Motexafin gadolinium: A redox-active tumor selective agent for the treatment of cancer. Curr. Opin. Oncol. 16 (2004) 576-580
71. Fedtke N., Boucheron J.A., Walker V.E., and Swenberg J.A. Vinyl chloride-induced DNA adducts. 2. Formation and persistence of 7-2′-oxoethylguanine and n2,3-ethenoguanine in rat-tissue DNA. Carcinogenesis 11 (1990) 1287-1292
72. Fink S.P., Reddy G.R., and Marnett L.J. Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 8652-8657
73. Firestein G.S., Echeverri F., Yeo M., Zvaifler N.J., and Green D.R. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 10895-10900
74. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1 (1995) 27-31
75. Fossel M. Cells, Aging and Human Disease (2003), Oxford University Press, New York
76. Foster M.W., and Stamler J.S. New insights into protein S-nitrosylation-Mitochondria as a model system. J. Biol. Chem. 279 (2004) 25891-25897
77. Frenette P.S., and Wagner D.D. Adhesion molecules. Part I. N. Engl. J. Med. 334 (1996) 1526-1529
78. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis-The good, the bad, and the ugly. Circ. Res. 90 (2002) 251-262
79. Galter D., Mihm S., and Dröge W. Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1. Eur. J. Biochem. 221 (1994) 639-648
80. Gerich J.E. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch. Int. Med. 163 (2003) 1306-1316
81. Gerschman R., Gilbert D.L., Nye S.W., Dwyer P., and Fenn W.O. Oxygen poisoning and x-irradiation-A mechanism in common. Science 119 (1954) 623-626
82. Ghafourifar P., and Cadenas E. Mitochondrial nitric oxide synthase. Trends Pharmacol. Sci. 26 (2005) 190-195
83. Gopalakrishna R., and Jaken S. Protein kinase C signaling and oxidative stress. Free Radic. Biol. Med. 28 (2000) 1349-1361
84. Granger D.N., Stokes K.Y., Shigematsu T., Cerwinka W.H., Tailor A., and Krieglstein C.F. Splanchnic ischaemia-reperfusion injury: Mechanistic insights provided by mutant mice. Acta Physiol. Scand. 173 (2001) 83-91
85. Grankvist K., Marklund S.L., and Taljedal I.B. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione-peroxidase in pancreatic-islets and other tissues in the mouse. Biochem. J. 199 (1981) 393-398
86. Griendling K.K., Sorescu D., Lasse'gue B., and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2175-2183
87. Hale A.J., Smith C.A., Sutherland L.C., Stoneman V.E.A., Longthorne V.L., Culhane A.C., et al. Apoptosis: Molecular regulation of cell death. Eur. J. Biochem. 236 (1996) 1-26
88. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine. 3rd ed. (1999), Oxford University Press
89. Hamuro J., Murata Y., Suzuki M., Takatsuki F., and Suga T. The triggering and healing of tumor stromal inflammatory reactions regulated by oxidative and reductive macrophages. Gann. Monograph Cancer Res. 48 (1999) 153-164
90. Han D., Canali R., Garcia J., Aguilera R., Gallaher T.K., and Cadenas E. Sites and mechanisms of aconitase inactivation by peroxynitrite: Modulation by citrate and glutathione. Biochemistry 44 (2005) 11986-11996
91. Hardy J.A., and Higgins G.A. Alzheimer's disease: The amyloid cascade hypothesis. Science 256 (1992) 184-185
92. Hare J.M., and Stamler J.S. NO/redox disequilibrium in the failing heart and cardiovascular system. J. Clin. Invest. 115 (2005) 509-517
93. Harman D. Aging-A theory based on free-radical and radiation-chemistry. J. Gerontol. 11 (1956) 298-300
94. Hayashi H., Iimuro M., Matsumoto Y., and Kaneko M. Effects of gamma-glutamylcysteine ethyl ester on heart mitochondrial creatine kinase activity: Involvement of sulfhydryl groups. Eur. J. Pharmacol. 349 (1998) 133-136
95. Hayat S.A., Patel B., Khattar R.S., and Malik R.A. Diabetic cardiomyopathy: Mechanisms, diagnosis and treatment. Clin. Sci. 107 (2004) 539-557
96. Hayflick L. How and why we age. Exp. Gerontol. 33 (1998) 639-653
97. Hehner S.P., Breitkreutz R., Shubinsky G., Unsoeld H., Schulze-Osthoff K., Schmitz M.L., et al. Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J. Immunol. 165 (2000) 4319-4328
98. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
99. Hilenski L.L., Clempus R.E., Quinn M.T., Lambeth J.D., and Griendling K.K. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 677-683
100. Hink U., Li H.G., Mollnau H., Oelze M., Matheis E., Hartmann M., et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 88 (2001) E14-E22
101. Hirota K., Murata M., Sachi Y., Nakamura H., Takeuchi J., Mori K., et al. Distinct roles of thioredoxin in the cytoplasm and in the nucleus-A two-step mechanism of redox regulation of transcription factor NF-kappa B. J. Biol. Chem. 274 (1999) 27891-27897
102. Hofseth L.J., Hussain S.P., and Harris C.C. p53: 25 years after its discovery. Trends Pharmacol. Sci. 25 (2004) 177-181
103. Hollstein M., Sidransky D., Vogelstein B., and Harris C.C. p53 mutations in human cancer. Science 253 (1991) 49-53
104. Huang X.D., Cuajungco M.P., Atwood C.S., Hartshorn M.A., Tyndall J.D.A., Hanson G.R., et al. CuII potentiation of Alzheimer A beta neurotoxicity-Correlation with cell-free hydrogen peroxide production and metal reduction. J. Biol. Chem. 274 (1999) 37111-37116
105. Ignarro L.J., and Kadowitz P.J. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Ann. Pharmacol. Toxicol. 25 (1985) 171-191
106. Ignarro L.J., Sisodia M., Trinh K., Bedrood S., Wu G.Y., Wei L.H., et al. Nebivolol inhibits vascular smooth muscle cell proliferation by mechanisms involving nitric oxide but not cyclic GMP. Nitric Oxide-Biol. Chem. 7 (2002) 83-90
107. Iles K.E., and Forman H.J. Macrophage signaling and respiratory burst. Immunol. Res. 26 (2002) 95-105
108. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 53 (2003) S26-S36
109. Jin L., and Yang H. Alpha-Synuclein aggregation and Parkinson's disease: Factors affecting the aggregation of alpha-synuclein. Prog. Biochem. Biophys. 33 (2006) 321-328
110. Jones D.P., Carlson J.L., Mody V.C., Cai J.Y., Lynn M.J., and Sternberg P. Redox state of glutathione in human plasma. Free Radic. Biol. Med. 28 (2000) 625-635
111. Jones S.P., Hoffmeyer M.R., Sharp B.R., Ho Y.S., and Lefer D.J. Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H277-H282
112. Jones S.A., O'donnell V.B., Wood J.D., Broughton J.P., Hughes E.J., and Jones O.T. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 271 (1996) H1626-H1634
113. Juranek I., and Bezek S. Controversy of free radical hypothesis: Reactive oxygen species-Cause or consequence of tissue injury?. Gen. Physiol. Biophys. 24 (2005) 263-278
114. Kakhlon O., and Cabantchik Z.I. The labile iron pool: Characterization, measurement, and participation in cellular processes. Free Radic. Biol. Med. 33 (2002) 1037-1046
115. Kalikiri P.C., and Sachan R.S.G.S. Ischemic and anesthetic preconditioning of the heart: An insight into the concepts and mechanisms. Internet J. Anesthesiol. 8 2 (2004)
116. 2+ pump by oxygen free-radicals. Am. J. Physiol. 257 (1989) H804-H811
117. Kaneto H., Kajimoto Y., Fujitani Y., Matsuoka T., Sakamoto K., Matsuhisa M., et al. Oxidative stress induces p21 expression in pancreatic islet cells: Possible implication in beta-cell dysfunction. Diabetologia 42 (1999) 1093-1097
118. Kasparova S., Brezova V., Valko M., Horecky J., Mlynarik V., Liptaj T., et al. Study of the oxidative stress in a rat model of chronic brain hypoperfusion. Neurochem. Int. 46 (2005) 601-611
119. Kaur D., Yantiri F., Rajagopalan S., Kumar J., Mo J.O., Boonplueang R., et al. Genetic or harmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease. Neuron 37 (2003) 899-909
120. Keisari Y., Braun L., and Flescher E. The oxidative burst and related phenomena in mouse macrophages elicited by different sterile inflammatory stimuli. Immunobiology 165 (1983) 78-89
121. Kern J.C., and Kehrer J.P. Free radicals and apoptosis: Relationships with glutathione, thioredoxin and the Bcl family of proteins. Front. Biosci. 10 (2005) 1727-1738
122. Keyse S.M., and Tyrrell R.M. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 99-103
123. Khan S.A., Kwangho L., Minhas K.M., Gonzales D.R., Raju S.V.Y., Tejani A.D., et al. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 15944-15948
124. Klatt P., and Lamas S. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur. J. Biochem. 267 (2000) 4928-4944
125. Kluck R.M., BossyWetzel E., Green D.R., and Newmeyer D.D. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275 (1997) 1132-1136
126. Kojo S. Vitamin C: Basic metabolism and its function as an index of oxidative stress. Curr. Med. Chem. 11 (2004) 1041-1064
127. Konig A., Menzel T., Lynen S., Wrazel L., Rosen A., Al-Katib A., et al. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis. Leukemia 11 (1997) 258-265
128. Koshland D.E. The molecule of the year. Science 258 (1992) 1861
129. Kovacic P., and Jacintho J.D. Mechanisms of carcinogenesis: Focus on oxidative stress and electron transfer. Curr. Med. Chem. 8 (2001) 773-796
130. Kovacic P., Pozos R.S., Somanathan R., Shangari N., and O'Brien P.J. Mechanism of mitochondrial uncouplers, inhibitors, and toxins: Focus on electron transfer, free radicals, and structure-activity relationships. Curr. Med. Chem. 12 (2005) 2601-2623
131. Krauss S., Zhang C.Y., Scorrano L., Dalgaard L.T., St-Pierre J., Grey S.T., et al. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J. Clin. Invest. 112 (2003) 1831-1842
132. Kuge S., and Jones N. YAP-1 dependent activation of TRX2 is essential for the response of Saccharomyces cerevisiae to oxidative stress by hydroperoxides. EMBO J. 13 (1994) 655-664
133. Kukreja R.C., and Hess M.L. The oxygen free-radical system-From equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc. Res. 26 (1992) 641-655
134. Kwong L.K., and Sohal R.S. Substrate and site specificity of hydrogen peroxide generation in mouse mitochondria. Arch. Biochem. Biophys. 350 (1998) 118-126
135. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81 (2001) 807-869
136. Lamas S., Marsden P.A., Li G.K., Tempst P., and Michel T. Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 6348-6352
137. Landis G.N., and Tower J. Superoxide dismutase evolution and life span regulation. Mech. Ageing Dev. 126 (2005) 365-379
138. Laude K., Favre J., Thuillez C., and Richard V. NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protection. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H2053-H2060
139. Laursen J.B., Rajagopalan S., Galis Z., Tarpey M., Freeman B.A., and Harrison D.G. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95 (1997) 588-593
140. Lawlor M.A., and Alessi D.R. PKB/Akt: A key mediator of cell proliferation, survival and insulin responses?. J. Cell. Sci. 114 (2001) 2903-2910
141. Lazou A., Bogoyevitch M.A., Clerk A., Fuller S.J., Marshall C.J., and Sugden P.H. Regulation of mitogen-activated protein kinase cas-cade in adult rat heart preparations in vitro. Circ. Res. 75 (1994) 932-941
142. Leonard S.S., Harris G.K., and Shi X. Metal-induced oxidative stress and signal transduction. Free Radic. Biol. Med. 37 (2004) 1921-1942
143. Li H.G., and Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 190 (2000) 244-254
144. Li J.M., and Shah A.M. ROS generation by nonphagocytic NADPH oxidase: Potential relevance in diabetic nephropathy. J. Am. Soc. Nephrol. 14 (2003) S221-S226
145. Ling X., Nagai R., Sakashita N., Takeya M., Horiuchi S., and Takahashi K. Immunohistochemical distribution and quantitative biochemical detection of advanced glycation end products in fetal to adult rats and in rats with streptozotocin-induced diabetes. Lab. Investig. 81 (2001) 845-861
146. Linsley P.S., and Ledbetter J.A. The role of the CD28 receptor during T cell responses to antigen. Ann. Rev. Immunol. 11 (1993) 191-212
147. 2 in the production of HO: In vitro and in vivo. Free Radic. Biol. Med. 16 (1994) 29-33
148. Liochev S.I., and Fridovich I. The Haber-Weiss cycle-70 years later: An alternative view. Redox Rep. 7 (2002) 55-57
149. Loft S., and Poulsen H.E. Cancer risk and oxidative DNA damage in man. J. Mol. Med. 74 (1996) 297-312
150. Lombardi V., Valko L., Stolc S., Valko M., Ondrejickova O., Horakova L., et al. Free radicals in rabbit spinal cord ischemia: Electron spin resonance spectroscopy and correlation with SOD activity. Cell. Mol. Neurobiol. 18 (1998) 399-412
151. Lopez-Ilasaca M., Crespo P., Pellici P.G., Gutkind J.S., and Wetzker R. Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 275 (1997) 394-397
152. Los M., Dröge W., Stricker K., Baeuerle P.A., and Schulze-Osthoff K. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol. 25 (1995) 159-165
153. Lowenstein C.J., Dinerman J.L., and Snyder S.H. Nitric-oxide-A physiological messenger. Ann. Intern. Med. 120 (1994) 227-237
154. Makropoulos V., Bruning T., and SchulzeOsthoff K. Selenium-mediated inhibition of transcription factor NF-kappa B and HIV-1 LTR promoter activity. Arch. Toxicol. 70 (1996) 277-283
155. Malaisse W.J., Malaisse-Lagae F., Sener A., and Pipeleers D.G. Determinants of the selective toxicity of alloxan to the pancreatic b-cell. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 927-930
156. Mao H., Schnetz-Boutaud N.C., Weisenseel J.P., Marnett L.J., and Stone M.P. Duplex DNA catalyzes the chemical rearrangement of a malondialdehyde deoxyguanosine adduct. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 6615-6620
157. Marnett L.J. Lipid peroxidation-DNA damage by malondialdehyde. Mut. Res-Fund. Mol. Mech Mutagen. 424 (1999) 83-95
158. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 21 (2000) 361-370
159. Masella R., Di Benedetto R., Vari R., Filesi C., and Giovannini C. Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes. J. Nutr. Biochem. 16 (2005) 577-586
160. Mates J.M., Perez-Gomez C., and De Castro I.N. Antioxidant enzymes and human diseases. Clin. Biochem. 32 (1999) 595-603
161. Matsumoto A., Comatas K.E., Liu L., and Stamler J.S. Screening for nitric oxide-dependent protein-protein interactions. Science 301 (2003) 657-661
162. Maurice M.M., Nakamura H., van der Voort E.A.M., van Vliet A.I., Staal F.J.T., Tak P.P., et al. Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J. Immunol. 158 (1997) 1458-1465
163. McCord J.M., and Fridovich I. Superoxide dismutase an enzymic function for erythrocuprein Hemocuprein. J. Biol. Chem. 244 (1969) 6049-6055
164. McCully J.D., and Levitsky S. Mitochondrial ATP-sensitive potassium channels in surgical cardioprotection. Arch. Biochem. Biophys. 420 (2003) 237-245
165. McEligot A.J., Yang S., and Meyskens F.L. Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells. Ann. Rev. Nutr. 25 (2005) 261-295
166. Meulener M., Whitworth A.J., Armstrong-Gold C.E., Rizzu P., Heutink P., Wes P.D., et al. Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr. Biol. 15 (2005) 1572-1577
167. Miller D.M., Buettner G.R., and Aust S.D. Transition metals as catalysts of "autoxidation" reactions. Free Radic. Biol. Med. 8 (1990) 95-108
168. Miller E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., and Guallar E. Meta-analysis: High-dosage Vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142 (2005) 37-46
169. Mittal C.K., and Murad F. Activation of guanylate cyclase by superoxide-dismutase and hydroxyl radical-Physiological regulator of guanosine 3′,5′-monophosphate formation. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 4360-4364
170. Molavi B., and Mehta J.L. Oxidative stress in cardiovascular disease: Molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr. Opin. Cardiol. 19 (2004) 488-493
171. Molkentin J.D., and Dorn G.W. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Ann. Rev. Physiol. 63 (2001) 391-426
172. Mortensen A., Skibsted L.H., and Truscott T.G. The interaction of dietary carotenoids with radical species. Arch. Biochem. Biophys. 385 (2001) 13-19
173. Mulder K.M. Role of Ras and MAPKs in TGF beta signaling. Cytokine Growth Fact. Rev. 11 (2000) 23-35
174. Muller F.L., Liu Y., and Van Remmen H. Complex III releases superoxide to both sides of the inner mitochondrial membrane. J. Biol. Chem. 279 (2004) 49064-49073
175. Nagase H., and Brew K. DesigningTIMP: Tissue inhibitor of metalloproteinases variants that are selective metalloproteinase inhibitors. Biochem. Soc. Symp. 70 (2003) 201-212
176. Nakamura H., Nakamura K., and Yodoi J. Redox regulation of cellular activation. Ann. Rev. Immunol. 15 (1997) 351-369
177. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13 (1999) 9-22
178. Newmeyer D.D., and Ferguson-Miller S. Mitochondria: Releasing power for life and unleashing the machineries of death. Cell 112 (2003) 481-490
179. Niedowicz D.M., and Daleke D.L. The role of oxidative stress in diabetic complications. Cell. Biochem. Biophys. 43 (2005) 289-330
180. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
181. Nogueira C.W., Zeni G., and Rocha J.B.T. Organoselenium and organotellurium compounds: Toxicology and pharmacology. Chem. Rev. 104 (2004) 6255-6285
182. Orrenius S., Zhivotovsky B., and Nicotera P. Regulation of cell death: The calcium-apoptosis link. Nat. Rev. Mol. Cell. Biol. 4 (2003) 552-565
183. Packer L., and Suzuki Y.J. Vitamin-E and alpha-lipoate-Role in antioxidant recycling and activation of the NF-kappa-b transcription factor. Mol. Aspects Med. 14 (1993) 229-239
184. Pande V., and Ramos M.J. Molecular recognition of 15-deoxy-delta(12,14)-prostaglandin J(2) by nuclear factor-kappa B and other cellular proteins. Bioorg. Med. Chem. Lett. 15 (2005) 4057-4063
185. Parekh A.B., and Penner R. Store depletion and calcium influx. Physiol. Rev. 77 (1997) 901-930
186. Pastor N., Weinstein H., Jamison E., and Brenowitz M. A detailed interpretation of OH radical footprints in a TBP DNA complex reveals the role of dynamics in the mechanism of sequence-specific binding. J. Mol. Biol. 304 (2000) 55-68
187. Pastore A., Federici G., Bertini E., and Piemonte F. Analysis of glutathione: Implication in redox and detoxification. Clin. Chim. Acta. 333 (2003) 19-39
188. Peng J., and Andersen J.K. The role of c-jun N-terminal kinase JNK in Parkinson's disease. IUBMB Life 55 (2003) 267-271
189. 2+-sensitizing property of xanthine oxidase inhibitors. Circul. Res. 83 (1998) 423-430
190. Petrosillo G., Ruggiero F.M., and Paradies G. Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria. FASEB J. 17 (2003) 2202-2208
191. Philchenkov A., Zavelevich M., Kroczak T.J., and Los M. Caspases and cancer: Mechanisms of inactivation and new treatment modalities. Exp. Oncol. 26 (2004) 82-97
192. Podrez E.A., Abu-Soud H.M., and Hazen S.L. Myeloperoxidase-generated
193. Pogocki D. Alzheimer's beta-amyloid peptide as a source of neurotoxic free radicals: The role of structural effects. Acta Neurobiol. Exp. 63 (2003) 131-145
194. Poli G., Leonarduzzi G., Biasi F., and Chiarpotto E. Oxidative stress and cell signalling. Curr. Med. Chem. 11 (2004) 1163-1182
195. Pourahmad J., and O'Brien P.J. Biological reactive intermediates that mediate chromium VI toxicity. Biol. React. Intermed. VI: Adv. Exp. Med. Biol. 500 (2001) 203-207
196. Pryor W.A. Vitamin E and heart disease: Basic science to clinical intervention trials. Free Radic. Biol. Med. 28 (2000) 141-164
197. Rae T.D., Schmidt P.J., Pufahl R.A., and O'Halloran T.V. Undetectable intracellular free copper: The requirement of a copper chaperone for superoxide dismutase. Science 284 (1999) 805-808
198. Rao A., Luo C., and Hogan P.G. Transcription factors of the NFAT family: Regulation and function. Ann. Rev. Immunol. 15 (1997) 707-747
199. Ridnour L.A., Isenberg J.S., Espey M.G., Thomas D.D., Roberts D.D., and Wink D.A. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 13147-13152
200. Ridnour L.A., Thomas D.D., Mancardi D., Espey M.G., Miranda K.M., Paolocci N., et al. The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol. Chem. 385 (2004) 1-10
201. Robertson R.P., Harmon J., Tran P.O., Tanaka Y., and Takahashi H. Glucose toxicity in beta-cells: Type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52 (2003) 581-587
202. Robertson R.P., Zhang H.J., Pyzdrowski K.L., and Walseth T.F. Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J. Clin. Invest. 90 (1992) 320-325
203. Robinson N.C. Functional binding of cardiolipin to cytochrome-c-oxidase. J. Bioen. Biomembr. 25 (1993) 153-163
204. Romero J.C., and Reckelhoff J.F. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 34 (1999) 943-949
205. Rosca M.G., Mustata T.G., Kinter M.T., Ozdemir A.M., Kern T.S., Szweda L.I., et al. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am. J. Physiol.-Renal Physiol. 289 (2005) F420-F430
206. Roy P., and Saha A. Metabolism and toxicity of arsenic: A human carcinogen. Curr. Sci. 82 (2002) 38-45
207. Sablina A.A., Budanov A.V., Ilyinskaya G.V., Agapova L.S., Kravchenko J.E., and Chumakov P.M. The antioxidant function of the p53 tumor suppressor. Nat. Med. 11 (2005) 1306-1313
208. Salmeen A., and Barford D. Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antiox. Redox. Signal. 7 (2005) 560-577
209. Santos F.W., Zeni G., Rocha J.B.T., Weis S.N., Fachinetto J.M., Favero A.M., et al. Diphenyl diselenide reverses cadmium-induced oxidative damage on mice tissues. Chem. Biol. Interact. 151 (2005) 159-165
210. Saretzki G., Petersen S., Petersen I., Kolble K., and von Zglinicki T. hTERT gene dosage correlates with telomerase activity in human lung cancer cell lines. Cancer Lett. 176 (2002) 81-91
211. Sayre L.M., Smith M.A., and Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8 (2001) 721-738
212. Schafer F.Q., and Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30 (2001) 1191-1212
213. Schaller M.D., Borgman C.A., Cobb B.S., Vines R.R., Reynolds A.B., and Parsons J.T. pp125fak a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci U.S.A. 89 (1992) 5192-5196
214. Schrauzer G.N. Interactive effects of selenium and chromium on mammary tumor development and growth in MMTV-infected female mice and their relevance to human cancer. Biol. Trace Element Res. 109 (2006) 281-292
215. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J. 10 (1991) 2247-2258
216. Semenza G.L. HIF-1: Mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88 (2000) 1474-1480
217. Sharma V., and McNeill J.H. Diabetic cardiomyopathy: Where are we 40 years later?. Can. J. Cardiol. 22 (2006) 305-308
218. Sharoni Y., Danilenko M., Dubi N., Ben-Dor A., and Levy J. Carotenoids and transcription. Arch. Biochem. Biophys. 430 (2004) 89-96
219. 2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem. J. 336 (1998) 241-246
220. Shen D., Dalton T.P., Nebert D.W., and Shertzer H.G. Glutathione redox state regulates mitochondrial reactive oxygen production. J. Biol. Chem. 280 (2005) 25305-25312
221. Sies H. Strategies of antioxidant defense. Eur. J. Biochem. 215 (1993) 213-219
222. Siems W.G., Grune T., and Esterbauer H. 4-Hydroxynonenal formation during ischemia and reperfusion of rat small-intestine. Life Sci. 57 (1995) 785-789
223. Skiles J.W., Gonnella N.C., and Jeng A.Y. The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors. Curr. Med. Chem. 11 (2004) 2911-2977
224. Skyschally A., Schulz R., Gres P., Korth H.G., and Heusch G. Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid. Am. J. Physiol. Heart. Circ. Physiol. 284 (2003) H698-H703
225. Smith A.R., Shenvi S.V., Widlansky M., Suh J.H., and Hagen T.M. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr. Med. Chem. 11 (2004) 1135-1146
226. Sowers J.R. Hypertension, angiotensin II, and oxidative stress. New Engl. J. Med. 346 (2002) 1999-2001
227. Stadtman E.R. Role of oxidant species in aging. Curr. Med. Chem. 11 (2004) 1105-1112
228. Stayner L.T., Dankovic D.A., and Lemen R.A. Occupational exposure to chrysotile asbestos and cancer risk: A review of the amphibole hypothesis. Am. J. Public Health 86 (1996) 179-186
229. Storz P. Reactive oxygen species in tumor progression. Front Biosci. 10 (2005) 1881-1896
230. Stoyanovsky D., Murphy T., Anno P.R., Kim Y.M., and Salama G. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21 (1997) 19-29
231. Sun T., and Oberley L.W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21 (1996) 335-348
232. Sundaresan M., Yu Z.X., Ferrans V.J., Sulciner D.J., Gutkind J.S., Irani K., et al. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem. J. 318 (1996) 379-382
233. Tamagno E., Bardini P., Guglielmotto M., Danni O., and Tabaton M. The various aggregation states of β-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression. Free Radic. Biol. Med. 41 (2006) 202-212
234. Tauber A.I., Borregaard N., Simons E., and Wright J. Chronic granulomatous disease: A syndrome of phagocyte oxidase deficiencies. Medicine 62 (1983) 286-309
235. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. J. Biol. Chem. 270 (1995) 30334-30338
236. Thannickal V.J., and Fanburg B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 279 (2000) L1005-L1028
237. Tomko Jr. R.J., Bansal P., and Lazo J.S. Airing out an antioxidant role for the tumor suppressor p53. Mol. Interv. 6 (2006) 23-25
238. Traverso N., Menini S., Odetti P., Pronzato M.A., Cottalasso D., and Marinari U.M. Diabetes impairs the enzymatic disposal of 4-hydroxynonenal in rat liver. Free Radic. Biol. Med. 32 (2002) 350-359
239. Tretter L., Sipos I., and Adam-Vizi V. Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease. Neurochem. Res. 29 (2004) 569-577
240. Valko M., Izakovic M., Mazur M., Rhodes C.J., and Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem. 266 (2004) 37-56
241. Valko M., Morris H., and Cronin M.T.D. Metals, toxicity and oxidative stress. Curr. Med. Chem. 12 (2005) 1161-1208
242. Valko M., Morris H., Mazur M., Rapta P., and Bilton R.F. Oxygen free radical generating mechanisms in the colon: Do the semiquinones of Vitamin K play a role in the aetiology of colon cancer?. Biochim. Biophys. Acta 1527 (2001) 161-166
243. Valko M., Rhodes C.J., Moncol J., Izakovic M., and Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160 (2006) 1-40
244. VanderJagt D.J., Harrison J.M., Ratliff D.M., Hunsaker L.A., and Vander Jagt D.L. Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin. Biochem. 34 (2001) 265-270
245. Vicent D., Ilany J., Kondo T., Naruse K., Fisher S.J., Kisanuki Y.Y., et al. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J. Clin. Invest. 111 (2003) 1373-1380
246. Voehringer D.W., Hirschberg D.L., Xiao J., Lu Q., Roederer M., Lock C.B., et al. Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 2680-2685
247. Vorbach C., Harrison R., and Capecchi M.R. Xanthine oxidoreductase is central to the evolution and function of the innate immune system. Trends Immunol. 24 (2003) 512-517
248. Waalkes M.P., Liu J., Ward J.M., and Diwan L.A. Mechanisms underlying arsenic carcinogenesis: Hypersensitivity of mice exposed to inorganic arsenic during gestation. Toxicology 198 (2004) 31-38
249. Wakasaki H., Koya D., Schoen F.J., Jirousek M.R., Ways D.K., Hoit B.D., et al. Targeted overexpression of protein kinase C beta 2 isoform in myocardium causes cardiomyopathy. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 9320-9325
250. Wang M.Y., Dhingra K., Hittelman W.N., Liehr J.G., deAndrade M., and Li D.H. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol. Biomark Prev. 5 (1996) 705-710
251. 2 tension. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 5510-5514
252. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in turner invasion. FASEB J. 13 (1999) 781-792
253. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86 (2001) 1930-1935
254. White M.F. The IRS-signalling system: A network of docking proteins that mediate insulin action Mol. Cell. Biochem. 182 (1998) 3-11
255. White E., Shannon J.S., and Patterson R.E. Relationship between Vitamin and calcium supplement use and colon cancer. Cancer Epidemiol. Biomark. Prevent. 6 (1997) 769-774
256. Wink D.A., Cook J.A., Kim S.Y., Vodovotz Y., Pacelli R., Krishna M.C., et al. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. J. Biol. Chem. 272 (1997) 11147-11151
257. Wolin M.S., Burke-Wolin T.M., and Mohazzab-H K.M. Roles of NADPH oxidases and reactive oxygen species in vascular oxygen sensing mechanisms. Respir. Physiol. 115 (1999) 229-238
258. Xie Q.W., Cho H.J., Calaycay J., Mumford R.A., Swiderek K.M., Lee T.D., et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256 (1992) 225-228
259. Xu K.Y., Huso D.L., Dawson T., Bredt D.S., and Becker L.C. NO synthase in cardiac sarcoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 657-662
260. Yamagishi S., Edelstein D., Du X.L., and Brownlee M. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes 50 (2001) 1491-1494
261. Yuan X.M., and Li W. The iron hypothesis of atherosclerosis and its clinical impact. Ann. Med. 35 (2003) 578-591
262. Zhao T.C., Hines D.S., and Kukreja R.C. Adenosine-induced late preconditioning in mouse hearts: Role of p38 MAP kinase and mitochondrial K (ATP) channels. Am. J. Physiol. Heart. Circ. Physiol. 280 (2001) H1278-H1285
263. Zou M.H., Shi C.M., and Cohen R.A. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 109 (2002) 817-826